{"id":19901,"date":"2023-02-10T08:54:12","date_gmt":"2023-02-10T08:54:12","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/se\/?page_id=19901"},"modified":"2023-03-28T07:08:33","modified_gmt":"2023-03-28T07:08:33","slug":"miguel-barrero","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\/","title":{"rendered":"MIGUEL BARRERO"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

https:\/\/www.linkedin.com\/in\/mbarrero\/<\/a><\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t
\n\t\t
Neuraxpharm<\/a><\/div>\n\t\t<\/div>\n\t\t<\/div>\n\t\t<\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

MIGUEL BARRERO DUR\u00c1N<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Miguel Barrero Dur\u00e1n \u00e4r Head of Business Development & Innovation och b\u00f6rjade p\u00e5 Neuraxpharm 2015. Han startade och utvecklade avdelningarna aff\u00e4rsutveckling och licensiering, allianshantering och nu senast Pipeline. Miguel leder ocks\u00e5 avdelningen f\u00f6r immaterialr\u00e4tt.<\/p>

Miguel har mer \u00e4n 22 \u00e5rs erfarenhet inom l\u00e4kemedelsindustrin i olika roller och p\u00e5 olika f\u00f6retag. Han b\u00f6rjade sin yrkeskarri\u00e4r 2000 p\u00e5 Almirall, f\u00f6r att sedan g\u00e5 vidare till Merck Serono 2005 och Esteve 2008 d\u00e4r han arbetade i ledarskapsroller inom l\u00e4kemedelsutveckling vilket gav honom en omfattande teknisk och vetenskaplig bakgrund.<\/p>

Innan han b\u00f6rjade p\u00e5 Neuraxpharm innehade han ett antal ledande befattningar inom aff\u00e4rsutveckling, bland annat extern licensiering p\u00e5 Invent Farma och Hetero Europe samt intern licensiering och aff\u00e4rsutveckling genom strategiska partnerskap och f\u00f6retagsutveckling.<\/p>

Han har en kandidatexamen i farmakologi fr\u00e5n University of Barcelona och en MBA fr\u00e5n det globala utbildningsinstitutet ESADE.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

https:\/\/www.linkedin.com\/in\/mbarrero\/ Neuraxpharm MIGUEL BARRERO DUR\u00c1N Miguel Barrero Dur\u00e1n \u00e4r Head of Business Development & Innovation och b\u00f6rjade p\u00e5 Neuraxpharm 2015. Han startade och utvecklade avdelningarna aff\u00e4rsutveckling och licensiering, allianshantering och nu senast Pipeline. Miguel leder ocks\u00e5 avdelningen f\u00f6r immaterialr\u00e4tt. Miguel har mer \u00e4n 22 \u00e5rs erfarenhet inom l\u00e4kemedelsindustrin i olika roller och p\u00e5 olika f\u00f6retag. […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1998,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-19901","page","type-page","status-publish","hentry"],"yoast_head":"\nMIGUEL BARRERO - Neuraxpharm SE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MIGUEL BARRERO\" \/>\n<meta property=\"og:description\" content=\"https:\/\/www.linkedin.com\/in\/mbarrero\/ Neuraxpharm MIGUEL BARRERO DUR\u00c1N Miguel Barrero Dur\u00e1n \u00e4r Head of Business Development & Innovation och b\u00f6rjade p\u00e5 Neuraxpharm 2015. Han startade och utvecklade avdelningarna aff\u00e4rsutveckling och licensiering, allianshantering och nu senast Pipeline. Miguel leder ocks\u00e5 avdelningen f\u00f6r immaterialr\u00e4tt. Miguel har mer \u00e4n 22 \u00e5rs erfarenhet inom l\u00e4kemedelsindustrin i olika roller och p\u00e5 olika f\u00f6retag. […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\/\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm SE\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-28T07:08:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.neuraxpharm.com\/se\/wp-content\/uploads\/sites\/29\/2023\/03\/m-barrero.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\/\",\"url\":\"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\/\",\"name\":\"MIGUEL BARRERO - Neuraxpharm SE\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/se\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.neuraxpharm.com\/se\/wp-content\/uploads\/sites\/29\/2023\/03\/m-barrero.jpg\",\"datePublished\":\"2023-02-10T08:54:12+00:00\",\"dateModified\":\"2023-03-28T07:08:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\/#primaryimage\",\"url\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/29\/2023\/03\/28070554\/m-barrero.jpg\",\"contentUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/29\/2023\/03\/28070554\/m-barrero.jpg\",\"width\":716,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.neuraxpharm.com\/se\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Allt om Neuraxpharm\",\"item\":\"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Verkst\u00e4llande utskott\",\"item\":\"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"MIGUEL BARRERO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/se\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/se\/\",\"name\":\"Neuraxpharm SE\",\"description\":\"A European Leader for the CNS products\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MIGUEL BARRERO - Neuraxpharm SE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero","og_locale":"sv_SE","og_type":"article","og_title":"MIGUEL BARRERO","og_description":"https:\/\/www.linkedin.com\/in\/mbarrero\/ Neuraxpharm MIGUEL BARRERO DUR\u00c1N Miguel Barrero Dur\u00e1n \u00e4r Head of Business Development & Innovation och b\u00f6rjade p\u00e5 Neuraxpharm 2015. Han startade och utvecklade avdelningarna aff\u00e4rsutveckling och licensiering, allianshantering och nu senast Pipeline. Miguel leder ocks\u00e5 avdelningen f\u00f6r immaterialr\u00e4tt. Miguel har mer \u00e4n 22 \u00e5rs erfarenhet inom l\u00e4kemedelsindustrin i olika roller och p\u00e5 olika f\u00f6retag. […]","og_url":"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\/","og_site_name":"Neuraxpharm SE","article_modified_time":"2023-03-28T07:08:33+00:00","og_image":[{"url":"https:\/\/www.neuraxpharm.com\/se\/wp-content\/uploads\/sites\/29\/2023\/03\/m-barrero.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\/","url":"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\/","name":"MIGUEL BARRERO - Neuraxpharm SE","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/se\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\/#primaryimage"},"image":{"@id":"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\/#primaryimage"},"thumbnailUrl":"https:\/\/www.neuraxpharm.com\/se\/wp-content\/uploads\/sites\/29\/2023\/03\/m-barrero.jpg","datePublished":"2023-02-10T08:54:12+00:00","dateModified":"2023-03-28T07:08:33+00:00","breadcrumb":{"@id":"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\/#primaryimage","url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/29\/2023\/03\/28070554\/m-barrero.jpg","contentUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/29\/2023\/03\/28070554\/m-barrero.jpg","width":716,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/miguel-barrero\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.neuraxpharm.com\/se\/"},{"@type":"ListItem","position":2,"name":"Allt om Neuraxpharm","item":"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/"},{"@type":"ListItem","position":3,"name":"Verkst\u00e4llande utskott","item":"https:\/\/www.neuraxpharm.com\/se\/allt-om-neuraxpharm\/verkstallande-utskott\/"},{"@type":"ListItem","position":4,"name":"MIGUEL BARRERO"}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/se\/#website","url":"https:\/\/www.neuraxpharm.com\/se\/","name":"Neuraxpharm SE","description":"A European Leader for the CNS products","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/se\/wp-json\/wp\/v2\/pages\/19901","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/se\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/se\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/se\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/se\/wp-json\/wp\/v2\/comments?post=19901"}],"version-history":[{"count":10,"href":"https:\/\/www.neuraxpharm.com\/se\/wp-json\/wp\/v2\/pages\/19901\/revisions"}],"predecessor-version":[{"id":19952,"href":"https:\/\/www.neuraxpharm.com\/se\/wp-json\/wp\/v2\/pages\/19901\/revisions\/19952"}],"up":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/se\/wp-json\/wp\/v2\/pages\/1998"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/se\/wp-json\/wp\/v2\/media?parent=19901"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}